Media Room

July 3, 2024

Jeff Hurwitz and Gordon Powell Join the Virax Biolabs Team

This week, we’re pleased to be welcoming Jeff Hurwitz and Gordon Powell to the team. Their decades of experience in the in-vitro diagnostics (IVD) space will be a great addition

June 21, 2024

Pioneering Viral Diagnostics with Dr. Nigel McCracken COO of Virax Biolabs

by Qualio

June 13, 2024

EVALUATING T-CELL DRIVEN IMMUNITY IN POST-VIRAL SYNDROMES

May 14, 2024

From Rugby Fields to Research Labs with Nigel McCracken (Spotify)

April 30, 2024

Nigel McCracken & Sean Knight – Research into T-Cell Exhaustion (with Jackie Baxter)

April 25, 2024

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

April 16, 2024

Virax Biolabs to Participate at ESCMID Global 2024

April 10, 2024

Post-Viral Syndromes and the Utility of T-cell Diagnostics

January 8, 2024

James Foster CEO & Nigel McCracken COO – Virax Biolabs (with Don Davis PhD)

January 4, 2024

Virax Biolabs Partners With University of Manchester, Northern Care Alliance on Long COVID Study

December 27, 2023

Identifying Post-Viral Syndromes Such as Long COVID

by John Parkinson

December 21, 2023

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients